Mauro J. David's Insider Trades & SAST Disclosures
Mauro J. David's most recent trade in Recursion Pharmaceuticals Inc - Ordinary Shares - Class A was a trade of 4,187 Class A Common Stock done at an average price of $6.2 . Disclosure was reported to the exchange on Nov. 15, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Mauro J. David.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Recursion Pharmaceuticals ... | David J. Mauro | Chief Medical Officer | 15 Nov 2024 | 4,187 | 225,429 | - | 6.2 | 25,855 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | David J. Mauro | Chief Medical Officer | 15 Aug 2024 | 14,146 | 229,616 | - | 6.7 | 94,637 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | David J. Mauro | Chief Medical Officer | 15 May 2024 | 867 | 243,762 | - | 10.0 | 8,679 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Mauro J. David | Chief Medical Officer | 09 Feb 2024 | 99,537 | 99,537 | - | - | Stock Option (RIght to Buy) | ||
| Recursion Pharmaceuticals ... | J. Mauro David | Chief Medical Officer | 09 Feb 2024 | 49,768 | 246,521 | - | 0 | Class A Common Stock | ||
| Recursion Pharmaceuticals ... | Mauro David J. | Chief Medical Officer | 09 Feb 2024 | 6,040 | 196,753 | - | 0 | Class A Common Stock | ||
| Recursion Pharmaceuticals ... | J. David Mauro | Chief Medical Officer | 09 Feb 2024 | 1,892 | 244,629 | - | 10.1 | 19,090 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | David J. Mauro | Chief Medical Officer | 01 Jun 2023 | 381,426 | 381,426 | - | - | Stock Option (Right to Buy) | ||
| Recursion Pharmaceuticals ... | David J. Mauro | Chief Medical Officer | 01 Jun 2023 | 190,713 | 190,713 | - | 0 | Class A Common Stock | ||
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Oct 2021 | 15,000 | 137,610 | - | - | Employee Stock Option (Right to Buy) | |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. | 05 Oct 2021 | 15,000 | 15,000 | - | 1.9 | 28,350 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 31.30 per share. | 05 Oct 2021 | 7,803 | 1,289 | - | 31.3 | 244,257 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 30.26 per share. | 05 Oct 2021 | 5,908 | 9,092 | - | 30.3 | 178,762 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 32.06 per share. | 05 Oct 2021 | 1,289 | 0 | - | 32.1 | 41,330 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Sep 2021 | 15,000 | 167,610 | - | - | Employee Stock Option (Right to Buy) | |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. | 07 Sep 2021 | 15,000 | 15,000 | - | 1.9 | 28,350 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 35.91 per share. | 07 Sep 2021 | 7,487 | 7,513 | - | 35.9 | 268,867 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 37.79 per share. | 07 Sep 2021 | 4,640 | 0 | - | 37.8 | 175,334 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 36.92 per share. | 07 Sep 2021 | 2,873 | 4,640 | - | 36.9 | 106,081 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. | 05 Aug 2021 | 15,000 | 15,000 | - | 1.9 | 28,350 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2021 | 15,000 | 167,610 | - | - | Employee Stock Option (Right to Buy) | |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 32.15 per share. | 05 Aug 2021 | 6,721 | 100 | - | 32.1 | 216,051 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 29.93 per share. | 05 Aug 2021 | 6,116 | 8,884 | - | 29.9 | 183,070 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 31.03 per share. | 05 Aug 2021 | 2,063 | 6,821 | - | 31.0 | 64,010 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 32.63 per share. | 05 Aug 2021 | 100 | 0 | - | 32.6 | 3,263 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2021 | 95,000 | 95,000 | - | - | Employee Stock Option (Right to Buy) | |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jul 2021 | 15,000 | 182,610 | - | - | Employee Stock Option (Right to Buy) | |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. | 06 Jul 2021 | 15,000 | 15,000 | - | 1.9 | 28,350 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 27.17 per share. | 06 Jul 2021 | 10,445 | 4,555 | - | 27.2 | 283,743 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 28.13 per share. | 06 Jul 2021 | 4,255 | 300 | - | 28.1 | 119,711 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 28.84 per share. | 06 Jul 2021 | 300 | 0 | - | 28.8 | 8,653 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. | 07 Jun 2021 | 15,000 | 15,000 | - | 1.9 | 28,350 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2021 | 15,000 | 197,610 | - | - | Common Stock | |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 32.73 per share. | 07 Jun 2021 | 12,700 | 0 | - | 32.7 | 415,665 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 30.35 per share. | 07 Jun 2021 | 1,400 | 13,600 | - | 30.4 | 42,496 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 31.62 per share. | 07 Jun 2021 | 900 | 12,700 | - | 31.6 | 28,462 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2021 | 15,000 | 212,610 | - | - | Common Stock | |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. | 05 May 2021 | 15,000 | 15,000 | - | 1.9 | 28,350 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 40.30 per share. | 05 May 2021 | 10,476 | 1,109 | - | 40.3 | 422,148 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 39.36 per share. | 05 May 2021 | 3,415 | 11,585 | - | 39.4 | 134,399 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 41.07 per share. | 05 May 2021 | 1,109 | 0 | - | 41.1 | 45,545 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2021 | 25,000 | 227,610 | - | - | Employee Stock Option (right to buy) | |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. | 27 Apr 2021 | 25,000 | 25,000 | - | 1.9 | 47,250 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 35.68 per share. | 27 Apr 2021 | 15,601 | 1,711 | - | 35.7 | 556,580 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 34.66 per share. | 27 Apr 2021 | 7,688 | 17,312 | - | 34.7 | 266,478 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 36.11 per share. | 27 Apr 2021 | 1,711 | 0 | - | 36.1 | 61,791 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2021 | 25,000 | 252,610 | - | - | Employee Stock Option (right to buy) | |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. | 19 Apr 2021 | 25,000 | 25,000 | - | 1.9 | 47,250 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 30.82 per share. | 19 Apr 2021 | 21,000 | 4,000 | - | 30.8 | 647,273 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 31.27 per share. | 19 Apr 2021 | 4,000 | 0 | - | 31.3 | 125,077 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2021 | 9,617 | 277,610 | - | - | Employee Stock Option (right to buy) | |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. | 08 Apr 2021 | 9,617 | 9,617 | - | 1.9 | 18,176 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 39.56 per share. | 08 Apr 2021 | 3,549 | 0 | - | 39.6 | 140,393 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 37.04 per share. | 08 Apr 2021 | 3,274 | 6,343 | - | 37.0 | 121,256 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 37.83 per share. | 08 Apr 2021 | 1,501 | 4,842 | - | 37.8 | 56,780 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 39.00 per share. | 08 Apr 2021 | 1,293 | 3,549 | - | 39.0 | 50,423 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. | 07 Apr 2021 | 15,383 | 15,383 | - | 1.9 | 29,074 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Apr 2021 | 15,383 | 287,227 | - | - | Employee Stock Option (right to buy) | |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 39.03 per share. | 07 Apr 2021 | 8,300 | 7,083 | - | 39.0 | 323,908 | Common Stock |
| Prelude Therapeutics Inc | David J. Mauro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 39.69 per share. | 07 Apr 2021 | 7,083 | 0 | - | 39.7 | 281,116 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges